Shares of Tandem Diabetes Care, Inc. (TNDM), an insulin delivery and diabetes technology company, are rising more than 7% Tuesday morning after the company said it received clearance from the FDA for its Tandem Mobi insulin pump for people aged 6 and more.
The Tandem Mobi, which can be fully controlled from a mobile app, is the world's smallest durable automated insulin delivery system, the company said.
TNDM is at $26.78 currently. It has traded in the range of $23.60 - $70.81 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.